14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for SELLAS Life Sciences Group Inc.
(Updated on May 03, 2024)

Buy candidate since May 02, 2024 Loss -1.48% PDF

The SELLAS Life Sciences Group Inc. stock price fell by -1.48% on the last day (Friday, 3rd May 2024) from $1.35 to $1.33. During the last trading day the stock fluctuated 6.20% from a day low at $1.29 to a day high of $1.37. The price has fallen in 5 of the last 10 days and is down by -13.64% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -435 thousand shares and in total, 772 thousand shares were bought and sold for approximately $1.03 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.26 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 76.47% during the next 3 months and, with a 90% probability hold a price between $2.22 and $3.05 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SLS Signals & Forecast

The SELLAS Life Sciences Group Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.34. On a fall, the stock will find some support from the long-term average at approximately $1.28. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -18.40%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for SELLAS Life Sciences Group Inc. stock

SELLAS Life Sciences Group Inc. finds support from accumulated volume at $1.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0800 between high and low, or 6.20%. For the last week the stock has had daily average volatility of 14.24%.

Our recommended stop-loss: $1.25 (-6.00%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (SLS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect SELLAS Life Sciences Group Inc. to open at $1.33, and during the day (based on 14 day Average True Range), to move between $1.18 and $1.48, which gives a possible trading interval of +/-$0.149 (+/-11.23%) up or down from last closing price. If SELLAS Life Sciences Group Inc. takes out the full calculated possible swing range there will be an estimated 22.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.28 (3.76%) than the resistance at $1.40 (5.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

SELLAS Life Sciences Group Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.210. We will update the financials statements for SELLAS Life Sciences Group Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.32% in the first trading day after earnings release.

Is SELLAS Life Sciences Group Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for SELLAS Life Sciences Group Inc. stock to perform well in the short-term.

Current score: 2.290 Buy Candidate Unchanged

Predicted Opening Price for SELLAS Life Sciences Group Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$1.33 ( 0%) $1.33

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.41 6.02 %
R2 1.38 3.72 %
R1 1.36 2.30 %
Current price: 1.33
Support S1 1.30 -2.30 %
S2 1.28 -3.72 %
S3 1.25 -6.02 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.54 15.79 %
R2 1.45 8.65 %
R1 1.40 5.26 %
Current price 1.33
Support S1 1.28 -3.76%
S2 1.10 -17.29%
S3 1.01 -24.06%

SLS Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 09, 2010 Dec 09, 2010 Dec 20, 2010 $0.420 0.0005%
2 Sep 07, 2010 Sep 09, 2010 Sep 22, 2010 $0.150 0.0002%

FAQ

What is the symbol for SELLAS Life Sciences Group Inc. Stock and on which exchange is it traded?
The symbol for SELLAS Life Sciences Group Inc. is SLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell SELLAS Life Sciences Group Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for SELLAS Life Sciences Group Inc. stock to perform well in the short-term.

How to buy SELLAS Life Sciences Group Inc. Stock?
SELLAS Life Sciences Group Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy SELLAS Life Sciences Group Inc. Stock.

What's the current price of SELLAS Life Sciences Group Inc. Stock?
As of the end of day on the May 03, 2024, the price of an SELLAS Life Sciences Group Inc. (SLS) share was $1.33.

What is the 52-week high and low for SELLAS Life Sciences Group Inc. Stock?
The 52-week high for SELLAS Life Sciences Group Inc. Stock is $1.91 and the 52-week low is $0.499.

What is the market capitalization of SELLAS Life Sciences Group Inc. Stock?
As of the May 03, 2024, the market capitalization of SELLAS Life Sciences Group Inc. is 75.961M.

When is the next earnings date for SELLAS Life Sciences Group Inc.?
The upcoming earnings date for SELLAS Life Sciences Group Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance... SLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT